-
Tempe
-
Lake Havasu City
-
Apache Junction
-
Parker
Xylazine-related offenses are increasingly prosecuted in Arizona and can result in felony charges, jail time, and long-term consequences for your future. Contact Matthew Lopez Law for a free consultation to understand your legal options.
Xylazine — known on the street as “tranq” — is reshaping drug enforcement in Arizona. This veterinary sedative has been showing up in the illicit drug supply at accelerating rates, typically mixed with fentanyl and heroin. It makes overdoses harder to reverse because xylazine is not an opioid — naloxone (Narcan) doesn’t counteract its effects on breathing, heart rate, and blood pressure.
The legal landscape around xylazine is evolving rapidly. As of early 2026, xylazine is not a federally scheduled controlled substance under the Controlled Substances Act, and Arizona has not independently scheduled it at the state level. But that does not mean you won’t face serious criminal charges if you’re caught with it. Here’s why.
If you’ve been arrested in connection with xylazine, call Matthew Lopez Law at (602) 680-9793 for a free consultation. We answer 24/7.
Federal level: Xylazine is not currently scheduled under the federal Controlled Substances Act (CSA). The DEA has issued public warnings about its dangers but lacks the regulatory authority to control it without congressional action. The bipartisan Combating Illicit Xylazine Act — which would classify illicit xylazine use with penalties equivalent to Schedule III controlled substances — has been advancing through Congress and was approved by the Senate Judiciary Committee in March 2026. Arizona’s Attorney General has joined a coalition of 39 state attorneys general supporting this legislation.
Arizona state level: Arizona has not enacted its own xylazine scheduling legislation. Unlike Ohio, Florida, Pennsylvania, and West Virginia — which have all taken steps to classify xylazine under their state controlled substances laws — Arizona currently lacks a standalone xylazine statute.
What this means in practice: Possessing pure xylazine, by itself, in Arizona currently occupies a legal gray area. However, xylazine is almost never encountered in isolation.
The practical reality is that xylazine-related arrests in Arizona almost always involve other controlled substances — primarily fentanyl. When law enforcement seizes drugs that contain xylazine, they prosecute based on whatever controlled substance the xylazine is mixed with:
Xylazine + fentanyl = ARS 13-3408 narcotic drug charges. Fentanyl is a narcotic drug under ARS 13-3401. If the mixture contains fentanyl, prosecutors charge the fentanyl offense. Simple possession is a Class 4 felony. Possession for sale is a Class 2 felony with up to 12.5 years. Threshold amounts trigger mandatory sentencing. The presence of xylazine in the mixture may actually increase the total weight, potentially pushing the fentanyl charge above threshold amounts.
Xylazine + heroin = ARS 13-3408 narcotic drug charges. Same analysis as fentanyl — heroin is a narcotic drug, and the 1-gram threshold applies.
Xylazine + methamphetamine = ARS 13-3407 dangerous drug charges. Meth carries its own mandatory sentencing framework with 5 to 15 years for sales-related offenses.
Xylazine + cocaine = ARS 13-3408 narcotic drug charges. Cocaine is a narcotic drug with a 9-gram threshold.
In every scenario, the controlled substance in the mixture drives the charge. The xylazine is relevant as an aggravating factor — it can increase total weight (affecting threshold calculations), signal drug trafficking activity, and serve as evidence of knowledge about the drug supply chain.
Even though Arizona hasn’t specifically scheduled xylazine, you can still face severe consequences:
Weight enhancement. When xylazine is mixed with fentanyl or heroin, the total weight of the mixture may be used to calculate whether threshold amounts are met. If xylazine adds enough weight to push the mixture above the statutory threshold, mandatory sentencing provisions activate — no probation, no early release. This is an area where defense attorneys can challenge whether the non-controlled adulterant should be included in the weight calculation.
Evidence of sophistication. Prosecutors use the presence of xylazine as evidence that a defendant is embedded in the drug trade. Xylazine isn’t something casual users add to their own supply — it’s typically introduced at the manufacturing or distribution level. This characterization can influence charging decisions (simple possession vs. for-sale) and sentencing arguments.
Federal exposure. Federal agencies are increasingly targeting xylazine-involved drug operations. The Office of National Drug Control Policy designated fentanyl adulterated with xylazine (FAAX) as an “emerging threat to the United States.” Federal investigations operating in Arizona — particularly on the I-10 and I-17 corridors — may pursue federal charges under 21 U.S.C. § 841 for the fentanyl component, with xylazine presence as an aggravating factor.
Rapidly changing law. The Combating Illicit Xylazine Act could be signed into law at any time, retroactively changing the enforcement landscape. Arizona could also pass its own scheduling legislation. What’s legal today may not be legal tomorrow — and pending legislation can influence how aggressively prosecutors pursue current cases.
Challenge the controlled substance identification. The charge is based on the scheduled drug in the mixture, not the xylazine. If lab testing is inconclusive about the presence of fentanyl, heroin, or another controlled substance — or if the chain of custody is broken — the charge may not hold.
Challenge the weight calculation. If prosecutors are using total mixture weight (including xylazine) to meet threshold amounts, we argue that only the weight of the actual controlled substance should count. This can be the difference between mandatory prison and probation eligibility.
Fourth Amendment challenges. The same search and seizure defenses that apply to all drug possession cases apply here. If the drugs were found through an illegal traffic stop, warrantless search, or coerced consent, the evidence gets suppressed.
Lack of knowledge. ARS 13-3408 and ARS 13-3407 require “knowing” conduct. If you didn’t know the substance you possessed contained fentanyl or another controlled drug — and you believed you possessed only xylazine — you have a knowledge defense. This is particularly relevant because xylazine is frequently added to the drug supply without the end user’s knowledge.
Constructive possession. Drugs found in shared spaces, vehicles with multiple occupants, or areas accessible to others don’t automatically prove possession. The prosecution must establish your knowledge and control.
Xylazine-related arrests commonly produce additional counts, including fentanyl charges (ARS 13-3408), heroin charges (ARS 13-3408), drug paraphernalia (ARS 13-3415), drug trafficking for larger quantities, endangerment if others were at risk, and manslaughter if someone died from a xylazine-fentanyl overdose.
Xylazine cases sit at the intersection of evolving law and aggressive enforcement. The legal gray areas create both risk and opportunity — but only if your attorney understands the current landscape and knows how to exploit the gaps. We monitor xylazine legislation at the state and federal level and adapt our defense strategies as the law changes.
We serve clients in Tempe, Mesa, Lake Havasu, Chandler, and throughout Arizona. Flat fees. Payment plans. Free consultation.
Google Reviews
Successfully Defended
For Arizona Residents
Fighting For You
"*" indicates required fields
This will close in 0 seconds